Bench-to-bedside translation of dendrimers: reality or utopia? A concise analysis

Mignani, Serge; Rodrigues, João; Tomás, Helena; Roy, René; Shi, Xiangyang; Majoral, Jean-Pierre

http://hdl.handle.net/10400.13/2439

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
Bench-to-bedside translation of dendrimers Reality or utopia.pdf		1.25 MB	Adobe PDF	Download

Send Feedback

Authors

Abstract(s)

Nanomedicine, which is an application of nanotechnologies in healthcare is developed to improve the treatments and lives of patients suffering from a range of disorders and to increase the successes of drug candidates. Within the nanotechnology universe, the remarkable unique and tunable properties of dendrimers have made them promising tools for diverse biomedical applications such as drug delivery, gene therapy and diagnostic. Up-to-date, very few dendrimers has yet gained regulatory approval for systemic administration, why? In this critical review, we briefly focus on the list of desired basic dendrimer requirements for decision-making purpose by the scientists (go/no-go decision), in early development stages, to become clinical candidates, and to move towards Investigational New Drugs (IND) application submission. In addition, the successful translation between research and clinic should be performed by the implementation of a simple roadmap to jump the 'valley of death' successfully.

Keywords

Dendrimers Nano carriers Clinical translation . Faculdade de Ciências Exatas e da Engenharia Centro de Química da Madeira

URI

http://hdl.handle.net/10400.13/2439

Citation

Mignani, S., Rodrigues, J., Tomas, H., Roy, R., Shi, X., & Majoral, J. P. (2018). Bench-to-bedside translation of dendrimers: reality or utopia? A concise analysis. Advanced drug delivery reviews, 136-137, 73-81.